About Vivus
Vivus is a publicly listed company based in Mountain View (United States) founded in 1991. Developer of therapeutic solutions for obesity and sexual health. The company has 59 employees. Vivus offers products and services including PANCREAZE and QSYMIA. Its focus areas include Life Sciences, Pulmonology, Drugs and Pulmonary Arterial Hypertension. Its legal entity is VIVUS LLC. Its competitors include Altimmune, Carmot and BioAge Labs; 3 of its 3 listed competitors have raised funding.
Company details
Vivus was established in 1991 in Mountain View, United States, within the pharmaceutical sector. Drug development and commercialization efforts are centered on treatments for obesity and sexual health conditions. A pipeline program featuring Tacrolimus is directed toward pulmonary arterial hypertension management. Operations encompass research, clinical trials, and market introduction of these therapies across the United States.
- Annual Revenue$69.76 M (USD)7as on Dec 31, 2019
- Net Profit-$31.5 M (USD)15as on Dec 31, 2019
- EBITDA-$10.97 M (USD)-215as on Dec 31, 2019
- Latest Funding Round$253M (USD), Post-IPO
May 2013
- Investors
- Employee Count59
Products & Services of Vivus
Vivus offers a comprehensive portfolio of products and services, including PANCREAZE and QSYMIA.
Manages Exocrine Pancreatic Insufficiency to reduce diarrhea and malnutrition.
Supports weight management through clinical treatment for obesity.
Funding Insights of Vivus
- Total Rounds 2
- Last Round Post-IPO — $253M
- Investors Count 1
All 2 funding rounds of Vivus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2013 | $253M | Post-IPO | – | – | – |
| Jun 1993 | Unspecified | – | – |
1 investors in total: 1 institutional.
Investors in Vivus
Vivus has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Frazier Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare sector private equity investments are managed by the firm. | 1991 | frazierhealthcare.com | Seattle, United States |
Investor details for Vivus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vivus
38 people are tracked at Vivus (18 in leadership, 20 in team); the tracked headcount is 59.
| Name | Role | Group |
|---|---|---|
Deborah Larsen | Vice President, Chief Strategy Officer | Leadership |
Santosh T. Varghese | President, VIVUS Global Pharmaceutical Development & Chief Medical Officer | Leadership |
Gregg Clark | Vice President, Marketing And Commercial Operations North America | Leadership |
John Amos | CEO | Leadership |
Eve Lai | VP, Human Resources | Leadership |
Kristina Warga | SVP & Chief Financial Officer | Leadership |
Melissa Shields | VP, Business Analytics & Digital Marketing | Leadership |
Charlie Swanson | VP, North America Sales | Leadership |
Alessandro Giacometti | VP & General Manager, Europe | Leadership |
Nadia Q. | Associate Director, Business Analytics | Leadership |
Julie Hollenback Jd (Miller) | Senior Director, Corporate & Legal Affairs | Leadership |
Tina Marie Czarnecki | National Sales Director | Leadership |
Rintu V. | Associate Director Quality Assurance | Leadership |
Ben Rowell | Director Sales Training And Area Sales | Leadership |
Rakesh Chand | Senior Director, Commercial & Regulatory Compliance | Leadership |
Laura Castagno | Director, European Regulatory Affairs | Leadership |
Shirley Wang | Director Of Fp&a | Leadership |
Vince Ho | Sr. Director | Leadership |
Kevin Smith | Senior Gastroenterology Sales Specialist | Team |
Todd Klein | Cardio-medabiolic Sales Speacialist | Team |
18 more people are available in the full profile.
Complete people profiles for Vivus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vivus
3 dated milestones of Vivus across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Vivus is founded.
- Funding First funding round.
- Funding Latest funding round, Post-IPO, of $253.0M.
Competitors of Vivus
Vivus has 3 listed competitors in our database, 3 of them funded. They include Altimmune, Carmot and BioAge Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| altimmune.com | 1997 | Gaithersburg, United States | $58M | 17 | Vaccines for infectious diseases and solid tumors are developed. | |
| carmot.us | 2008 | Berkeley, United States | $385.52M | Disease-modifying therapies for metabolic diseases are developed. | ||
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. |
Detailed competitors of Vivus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Vivus
The website of Vivus (vivus.com) receives about 3K visits a month.
- Monthly visits3K
▼ 15.4% vs previous month
Websites whose visitors overlap most with Vivus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| molinahealthcare.com | 100% | 1.3M | #42,785 | View details | |
amerigroupcorp.com | amerigroupcorp.com | 100% | – | ||
| humana.com | 100% | 10.5M | #4,629 | View details | |
| cigna.com | 74% | 12.8M | #3,957 | View details | |
| arenapharm.com | 56% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Vivus
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Obesity
3 companies that operate in the same segment as Vivus (Obesity) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Bioinformatics platform is provided for biomarkers and drug discovery. | 2015 | Vallejo, California, United States | USD 293.9 M | USD 8.99 M | 64 | |
Disease-modifying therapies for metabolic diseases are developed. | 2008 | Berkeley, California, United States | USD 385.52 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vivus
Complete news archive for Vivus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivus
Vivus was founded in 1991 and raised its 1st funding round 2 years after it was founded.
Vivus is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Vivus has 59 employees.
Annual revenue of Vivus is $69.76M as on Dec 31, 2019.
Vivus was established in 1991 in Mountain View, United States, within the pharmaceutical sector. Drug development and commercialization efforts are centered on treatments for obesity and sexual health conditions. A pipeline program featuring Tacrolimus is directed toward pulmonary arterial hypertension management. Operations encompass research, clinical trials, and market introduction of these therapies across the United States.
Vivus's top competitors include BioAge Labs, Carmot and Altimmune.
Vivus offers PANCREAZE and QSYMIA.
Vivus has 1 investor. Key investors include Frazier Healthcare Partners.
Vivus operates through Vivus Llc.